RU2223492C2 - Protein obtained from neisseria meningitidis (variants, its fragment, nucleic acid encoding thereof (variants), probe, primer, composition - Google Patents

Protein obtained from neisseria meningitidis (variants, its fragment, nucleic acid encoding thereof (variants), probe, primer, composition Download PDF

Info

Publication number
RU2223492C2
RU2223492C2 RU2001112411/13A RU2001112411A RU2223492C2 RU 2223492 C2 RU2223492 C2 RU 2223492C2 RU 2001112411/13 A RU2001112411/13 A RU 2001112411/13A RU 2001112411 A RU2001112411 A RU 2001112411A RU 2223492 C2 RU2223492 C2 RU 2223492C2
Authority
RU
Russia
Prior art keywords
fragment
nucleic acid
protein
neisseria meningitidis
nucleotide sequence
Prior art date
Application number
RU2001112411/13A
Other languages
Russian (ru)
Other versions
RU2001112411A (en
Inventor
Клэр М. ФРЭЙЗЕР (US)
Клэр М. ФРЭЙЗЕР
Эрин ХИКЕЙ (US)
Эрин ХИКЕЙ
Джереми ПЕТЕРСОН (US)
Джереми ПЕТЕРСОН
Эрве ТЕТТЕЛИН (US)
Эрве ТЕТТЕЛИН
Дж. Крэйг ВЕНТЕР (US)
Дж. Крэйг ВЕНТЕР
Вега МАСИНЬЯНИ (IT)
Вега Масиньяни
Чезира ГАЛЕОТТИ (IT)
Чезира ГАЛЕОТТИ
Марироза МОРА (IT)
Марироза МОРА
Джулио РАТТИ (IT)
Джулио РАТТИ
Мари СКАРСЕЛЛИ (IT)
Мария СКАРСЕЛЛИ
Винченцо СКАРЛАТО (IT)
Винченцо СКАРЛАТО
Рино РАППУОЛИ (IT)
Рино РАППУОЛИ
Мариаграти ПИЦЦА (IT)
Мариагратия ПИЦЦА
Гвидо ГРАНДИ (IT)
Гвидо ГРАНДИ
Original Assignee
Чирон Корпорейшн
Дзе Инститьют Фор Дженомик Рисерч
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Чирон Корпорейшн, Дзе Инститьют Фор Дженомик Рисерч filed Critical Чирон Корпорейшн
Publication of RU2001112411A publication Critical patent/RU2001112411A/en
Application granted granted Critical
Publication of RU2223492C2 publication Critical patent/RU2223492C2/en

Links

Images

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

FIELD: molecular biology, biotechnology, proteins. SUBSTANCE: invention relates to methods for preparing immunogenic proteins from Neisseria genome sequences including amino acid sequences given in the description and corresponding nucleotide sequences given in the description and Neisseria meningitides genome sequence also. Invention provides using prepared proteins as antigens for vaccines, immunogenic compositions and/or diagnostic reagents. EFFECT: improved preparing method, valuable properties of protein. 15 cl, 53 dwg

Description

Текст описания в факсимильном виде (см. графический материал) Description text in facsimile form (see graphic material)

Claims (15)

1. Белок, полученный из Neisseria meningitidis, проявляющий свойства антигена, включающий аминокислотную последовательность, кодируемую нуклеотидной последовательностью SEQ ID NO:35.1. A protein obtained from Neisseria meningitidis exhibiting antigenic properties, including the amino acid sequence encoded by the nucleotide sequence of SEQ ID NO: 35. 2. Белок, полученный из Neisseria meningitidis, проявляющий свойства антигена, включающий аминокислотную последовательность, которая более чем на 80% идентична аминокислотной последовательности, кодируемой нуклеотидной последовательностью SEQ ID NO:35.2. A protein obtained from Neisseria meningitidis exhibiting antigenic properties comprising an amino acid sequence that is more than 80% identical to the amino acid sequence encoded by the nucleotide sequence of SEQ ID NO: 35. 3. Фрагмент белка, полученный из Neisseria meningitidis, проявляющий свойства антигена, состоящий по крайней мере из 10 аминокислот аминокислотной последовательности, кодируемой нуклеотидной последовательностью SEQ ID NO:35.3. A protein fragment obtained from Neisseria meningitidis exhibiting antigenic properties consisting of at least 10 amino acids of the amino acid sequence encoded by the nucleotide sequence of SEQ ID NO: 35. 4. Нуклеиновая кислота, кодирующая белок, полученный из Neisseria meningitidis, проявляющий свойства антигена, включающая нуклеотидную последовательность SEQ ID NO:35.4. A nucleic acid encoding a protein derived from Neisseria meningitidis, exhibiting antigenic properties, including the nucleotide sequence of SEQ ID NO: 35. 5. Нуклеиновая кислота по п.4, отличающаяся тем, что она кодирует белок по п.1 или его фрагмент по п.3.5. The nucleic acid according to claim 4, characterized in that it encodes a protein according to claim 1 or its fragment according to claim 3. 6. Нуклеиновая кислота, кодирующая белок, полученный из Neisseria meningitidis, проявляющий свойства антигена, включающая нуклеотидную последовательность, которая более чем на 80% идентична нуклеотидной последовательности SEQ ID NO:35.6. A nucleic acid encoding a protein derived from Neisseria meningitidis exhibiting antigenic properties comprising a nucleotide sequence that is more than 80% identical to the nucleotide sequence of SEQ ID NO: 35. 7. Нуклеиновая кислота по п.6, отличающаяся тем, что она кодирует белок по п.1 или 2, или его фрагмент по п.3.7. The nucleic acid according to claim 6, characterized in that it encodes a protein according to claim 1 or 2, or a fragment thereof according to claim 3. 8. Фрагмент нуклеиновой кислоты, кодирующий фрагмент белка, полученный из Neisseria meningitidis, проявляющий свойства антигена, состоящий из 100 или более нуклеотидов нуклеотидной последовательности SEQ ID NО:35.8. A nucleic acid fragment encoding a protein fragment obtained from Neisseria meningitidis exhibiting antigenic properties consisting of 100 or more nucleotides of the nucleotide sequence of SEQ ID NO: 35. 9. Фрагмент нуклеиновой кислоты по п.8, отличающийся тем, что он кодирует фрагмент белка по п.3.9. The nucleic acid fragment of claim 8, characterized in that it encodes a protein fragment of claim 3. 10. Нуклеиновая кислота, кодирующая белок по п.1 или 2, или его фрагмент по п.3.10. A nucleic acid encoding a protein according to claim 1 or 2, or a fragment thereof according to claim 3. 11. Нуклеиновая кислота, комплементарная нуклеиновой кислоте по любому из пп.4, 6 или ее фрагменту по п.8.11. A nucleic acid complementary to a nucleic acid according to any one of claims 4, 6 or a fragment thereof according to claim 8. 12. Зонд, включающий нуклеиновую кислоту по любому из пп.4-7, 10 или 11, или ее фрагмент по п.8 или 9.12. A probe comprising a nucleic acid according to any one of claims 4 to 7, 10 or 11, or a fragment thereof according to claim 8 or 9. 13. Праймер для амплификации, включающий нуклеиновую кислоту по любому из пп.4, 6 или ее фрагмент по п.8.13. A primer for amplification, comprising a nucleic acid according to any one of claims 4, 6 or a fragment thereof according to claim 8. 14. Композиция для лечения или профилактики инфекции, вызванной Neisseria meningitidis, или для выявления наличия Neisseria meningitidis или антител, индуцированных против Neisseria meningitidis, включающая эффективное количество соединения, выбранного из группы, состоящей из (а) нуклеиновой кислоты по любому из пп.4-7, 10 или 11, или ее фрагмента по п.8 или 9; и/или (b) белка по п.1 или 2, или его фрагмента по п.3, и фармацевтически приемлемый носитель.14. A composition for treating or preventing an infection caused by Neisseria meningitidis, or for detecting the presence of Neisseria meningitidis or antibodies induced against Neisseria meningitidis, comprising an effective amount of a compound selected from the group consisting of (a) a nucleic acid according to any one of claims 4- 7, 10 or 11, or a fragment thereof according to claim 8 or 9; and / or (b) the protein according to claim 1 or 2, or a fragment thereof according to claim 3, and a pharmaceutically acceptable carrier. 15. Композиция по п.14, используемая в качестве лекарственного средства или диагностического реагента.15. The composition of claim 14, used as a medicine or diagnostic reagent.
RU2001112411/13A 1998-10-09 1999-10-08 Protein obtained from neisseria meningitidis (variants, its fragment, nucleic acid encoding thereof (variants), probe, primer, composition RU2223492C2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10379498P 1998-10-09 1998-10-09
US60/103,794 1998-10-09
US60/132,068 1999-04-30

Publications (2)

Publication Number Publication Date
RU2001112411A RU2001112411A (en) 2003-06-10
RU2223492C2 true RU2223492C2 (en) 2004-02-10

Family

ID=32174119

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2001112411/13A RU2223492C2 (en) 1998-10-09 1999-10-08 Protein obtained from neisseria meningitidis (variants, its fragment, nucleic acid encoding thereof (variants), probe, primer, composition

Country Status (2)

Country Link
CN (1) CN1911959A (en)
RU (1) RU2223492C2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2557315C2 (en) * 2009-03-24 2015-07-20 Новартис Аг Factor h-binding adjuvant meningococcal protein
RU2665841C2 (en) * 2012-03-09 2018-09-04 Пфайзер Инк. Neisseria meningitidis compositions and methods of use thereof
RU2776310C2 (en) * 2012-03-09 2022-07-18 Пфайзер Инк. Neisseria meningitidis compositions and their application methods

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109456974A (en) * 2018-07-02 2019-03-12 广西医科大学 A kind of Endoglin aptamer and its application
CN109161547B (en) * 2018-09-20 2021-11-09 广西科学院 Nucleic acid aptamer and application thereof in detection of pathogenic vibrio alginolyticus

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ЩЕЛКУНОВ С.Н. Конструирование гибридных молекул ДНК. - Новосибирск, Наука, 1987, с. 205-224. *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2557315C2 (en) * 2009-03-24 2015-07-20 Новартис Аг Factor h-binding adjuvant meningococcal protein
RU2665841C2 (en) * 2012-03-09 2018-09-04 Пфайзер Инк. Neisseria meningitidis compositions and methods of use thereof
RU2739504C2 (en) * 2012-03-09 2020-12-25 Пфайзер Инк. Neisseria meningitidis compositions and methods for using them
RU2776310C2 (en) * 2012-03-09 2022-07-18 Пфайзер Инк. Neisseria meningitidis compositions and their application methods

Also Published As

Publication number Publication date
CN1911959A (en) 2007-02-14

Similar Documents

Publication Publication Date Title
CA2438080A1 (en) Gonococcal proteins and nucleic acids
CN1211488C (en) Modified plant viruses as vectors of heterologous peptides
RU2000118777A (en) MULTI-SYSTEM PIG EMISSION SYNDROME VIRUS IN PIG-WEATHER
BR9914374A (en) Genetic sequences of neisseria and methods for its use
BR9712852A (en) Plasmid, composition, process of immunizing an individual against a pathogen, recombinant vaccine, live attenuated pathogen, substantially pure bl-1 protein, recombinant expression vector, and isolated antibody
JP2005097311A (en) Antigen
JPS61143327A (en) Multi-effective immunologic protein
KR970703425A (en) Hepatitis G virus and its molecular cloning method (HEPATITIS G VIRUS AND MO-LECULAR CLONING THEREOF)
KR930702942A (en) Recombinant Cat Coronavirus S Protein
CN1020857C (en) Peptides corresponding to antigenic and immunogenic determinants of major nentralizing proteins of rotaviruses
RU2223492C2 (en) Protein obtained from neisseria meningitidis (variants, its fragment, nucleic acid encoding thereof (variants), probe, primer, composition
CN113574073A (en) Peptide immunogens directed against calcitonin gene-related peptide (CGRP) and formulations thereof for the prevention and treatment of migraine
KR100366482B1 (en) Unclassified Haemophilus influenzae P5 protein purified as a vaccine, and methods for purifying it
US5061623A (en) Peptides comprising an immunogenic site of poliovirus and dnas containing nucleotide sequences coding for these peptides
EP0120906B1 (en) Polypeptides useful in vaccination against enteroviruses
NZ520600A (en) Novel therapeutic compositions for treating infection by Lawsonia spp
KR100425884B1 (en) DNA sequence encoding the specific and antigenic outer membrane protein of Salmonella typhi
KR20030074593A (en) Rabbit hemorrhagic disease vaccine and antigens
CA2491726A1 (en) Feline infectious peritonitis vaccine
CA2399846A1 (en) Gm-negative ehv-mutants
WO1998030699A1 (en) POLYNUCLEOTIDE CODING FOR A 27 kD POLYPEPTIDE OF MYCOBACTERIA BELONGING TO THE TUBERCULOSIS MYCOBACTERIUM COMPLEX, APPLICATION TO THE DIAGNOSIS AND TO THE PREVENTION OF TUBERCULOSIS
AU2009230776B2 (en) Neisseria meningitidis antigens and compositions
JP2002360285A5 (en)
CA2088988A1 (en) Plasmodium falciparum antigen for eliciting protective antibodies for use in vaccines
EP1922416A2 (en) Antigens for vaccination against and detection of mycoplasma suis

Legal Events

Date Code Title Description
PD4A Correction of name of patent owner
TK4A Correction to the publication in the bulletin (patent)

Free format text: AMENDMENT TO CHAPTER -FG4A- IN JOURNAL: 4-2004 FOR TAG: (73)

PC43 Official registration of the transfer of the exclusive right without contract for inventions

Effective date: 20100802

MM4A The patent is invalid due to non-payment of fees

Effective date: 20141009